No medical treatments have been clearly shown to stop or slow the underlying disease process in Alzheimer’s disease. However, some medication can improve symptoms. Acetylcholinesterase inhibitors can improve cognitive function in people with Alzheimer’s disease, although the effect is generally small.[1]
In 2020, a medication called aducanumab was approved by the FDA for the treatment of Alzheimer’s disease based on its effects on amyloid plaques, but whether aducanumab improves clinical outcomes (e.g., cognitive function) remains to be established.[2]
References
- ^Marucci G, Buccioni M, Ben DD, Lambertucci C, Volpini R, Amenta FEfficacy of acetylcholinesterase inhibitors in Alzheimer's disease.Neuropharmacology.(2021-06-01)
- ^Tampi RR, Forester BP, Agronin MAducanumab: evidence from clinical trial data and controversies.Drugs Context.(2021)